Saitama Medical University APEX Trial: Clopidogrel Useful In Cerebral Infarction Prevention
This article was originally published in PharmAsia News
The administration of Plavix (clopidogrel) has proved effective in the treatment of non-cardiogenic acute cerebral infarction, according to Saitama University International Medical Center Deputy Director Norio Tanahashi, who spoke recently at a Sanofi-sponsored seminar in Japan.
You may also be interested in...
In a 1 June speech before the Alliance For a Stronger FDA, US FDA commissioner Stephen Hahn stressed the agency’s vigilance in guarding against consumer use of flawed COVID-19 products. He also made comments about the need for doctors to communicate more with patients. See what he said about the use of telehealth here.
Request for documents and a briefing is part of efforts to ensure federal programs are ‘protected from price gouging.’
Merck’s Frazier Urges Businesses To Use ‘Every Instrument At Their Disposal’ To Reduce Racial Inequity
‘What we have to guard against is that when the streets quiet down … a lot of people are going to go back to their normal lives,’ Merck CEO Ken Frazier says in an interview with CNBC.